ALS（筋萎縮性側索硬化症） 治験結果
-
Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects
-
Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (AL
-
Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)
-
Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Cla
-
Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis
-
Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS
-
Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)
-
Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy
-
Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis
-
Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial
-
Ph1 T-Regulatory Cells in Amyotrophic Lateral Sclerosis
-
Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS
-
Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult Subjects
-
Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)
-
HEALEY ALS Platform Trial - Regimen G DNL343
疾患別の治験
肺がん非小細胞肺がん乳がん大腸がん胃がん肝がん膵臓がん前立腺がん卵巣がんメラノーマ白血病リンパ腫多発性骨髄腫膠芽腫2型糖尿病肥満症高血圧心不全心房細動脳卒中慢性腎臓病非アルコール性脂肪肝炎アルツハイマー病パーキンソン病多発性硬化症うつ病てんかんALS（筋萎縮性側索硬化症）関節リウマチ乾癬アトピー性皮膚炎クローン病潰瘍性大腸炎全身性エリテマトーデス喘息COPD（慢性閉塞性肺疾患）